1. Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors

   • Nicki Niemann
   • Joseph Jankovic

   Therapy in Practice 26 February 2018 Pages: 525 - 541

   

2. Episodic Breathlessness in Patients with Advanced Cancer: Characteristics and Management

   • Sebastiano Mercadante

   Review Article 22 February 2018 Pages: 543 - 547

3. BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers

   • Jaquelyn N. Sanchez
   • Ton Wang
   • Mark S. Cohen

   Review Article 27 February 2018 Pages: 549 - 566

   

4. Contemporary Drug Treatment of Hypertension: Focus on Recent Guidelines

   • Wilbert S. Aronow
   • William H. Frishman

   Review Article 13 March 2018 Pages: 567 - 576

5. Sofosbuvir/Velpatasvir/Voxilaprevir: A Review in Chronic Hepatitis C

   • Young-A Heo
   • Emma D. Deeks

   Adis Drug Evaluation 15 March 2018 Pages: 577 - 587

   

6. OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine

   • James E. Frampton
   • Stephen Silberstein

   Adis Drug Evaluation Open access 12 March 2018 Pages: 589 - 600

   

7. Bictegravir: First Global Approval

   • Anthony Markham

   AdisInsight Report 21 March 2018 Pages: 601 - 606

   

8. Correction to: Eculizumab: A Review in Generalized Myasthenia Gravis

   • Sohita Dhillon

   Correction Open access 09 March 2018 Pages: 607 - 607

9. Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors

   • Nicki Niemann
   • Joseph Jankovic

   Correction 10 March 2018 Pages: 609 - 609